Legend Biotech (LEGN) Event Aug. 05, 2022, 12:30 UTC (10% Negative) Legend Biotech (LEGN) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 6:48 p.m. 🌍 Legend Biotech (LEGN) - Form 6-K Filing Filing Date: 2022-08-05 Accepted: 2022-08-05 08:30:29 Event Type: Clinical Trial Update Event Details: Legend Biotech expects to record a loss of approximately US$196 million to US$228.9 million for the six-months ended June 30, 2022. The company expects an adjusted loss for the period of about US$144.5 million toUS$168.6 million, in each case. 💼 Business Developments: ✅ Partnership/Collaboration❌ Acquisition Activity: Not reported❌ Licensing Agreement: Not reported❌ Regulatory Milestone: Not reported❌ Leadership Updates: Not reported 📞 Contact Information: Email: Joanne.choi@legendbiotech.com
🌍 Legend Biotech (LEGN) - Form 6-K Filing
Filing Date: 2022-08-05
Accepted: 2022-08-05 08:30:29
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: